HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goldmann, D. A. Articles by Moellering, R. C. Search for Related Content PubMed PubMed Citation Articles by Goldmann, D. A. Articles by Moellering, R. C., Jr

The Journal of Thoracic and Cardiovascular Surgery, Vol 73, 470-479, Copyright © 1977 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Cephalothin prophylaxis in cardiac valve surgery. A prospective, double- blind comparison of two-day and six-day regimens

DA Goldmann, CC Hopkins, AW Karchmer, RM Abel, MT McEnany, C Akins, MJ Buckley and RC Moellering Jr

A prospective, double-blind study comparing a 6 day with a 2 day regimen of cephalothin prophylaxis was conducted among 200 patients undergoing prosthetic valve replacement. No cases of endocarditis occurred during the 2 month follow-up. Sternal wound infection developed in 2.8 per cent of the 6 day group and 2.1 per cent of the 2 day group. Pneumonia developed in 8.5 per cent of the 6 day and 5.3 per cent of the 2 day group; most of the bacteria isolated were susceptible to cephalothin. Urinary tract infection developed more frequently in the 2 day group (17.0 versus 8.5 per cent), particularly during the first 6 postoperative days. Three of 11 patients with no detectable cephalothin in their sera at the close of operation developed staphylococcal wound infections, compared with 2 of 175 patients whose sera contained cephalothin at the close of surgery (p = 0.002, Fisher's exact test). A short course of prophylactic antibiotics is prudent, but there is no justification for prolonging their administration.

This article has been cited by other articles:

				E. P. Dellinger Prophylactic Antibiotics: Administration and Timing before Operation Are More Important than Administration after Operation Clinical Infectious Diseases, April 1, 2007; 44(7): 928 - 930. [Full Text] [PDF]

				R. Ragusa, G. Faggian, A. Rungatscher, D. Cugola, A. Marcon, and A. Mazzucco Use of gelatin powder added to rifamycin versus bone wax in sternal wound hemostasis after cardiac surgery Interact CardioVasc Thorac Surg, February 1, 2007; 6(1): 52 - 55. [Abstract] [Full Text] [PDF]

				D. W. Bratzler, P. M. Houck, C. Richards, L. Steele, E. P. Dellinger, D. E. Fry, C. Wright, A. Ma, K. Carr, and L. Red Use of Antimicrobial Prophylaxis for Major Surgery: Baseline Results From the National Surgical Infection Prevention Project Arch Surg, February 1, 2005; 140(2): 174 - 182. [Abstract] [Full Text] [PDF]

				M.-R. Movahed, B. Kasravi, and C. S. Bryan Prophylactic Use of Vancomycin in Adult Cardiology and Cardiac Surgery Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1): 13 - 20. [Abstract] [PDF]

				R. Salenger, J. S. Gammie, and T. J. Vander Salm Postoperative Care of Cardiac Surgical Patients Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469. [Full Text]

				T. P. Carrel, E. Eisinger, M. Vogt, and M. I. Turina Pneumonia after cardiac surgery is predictable by tracheal aspirates but cannot be prevented by prolonged antibiotic prophylaxis Ann. Thorac. Surg., July 1, 2001; 72(1): 143 - 148. [Abstract] [Full Text] [PDF]

				I. Kriaras, A. Michalopoulos, M. Turina, and S. Geroulanos Evolution of antimicrobial prophylaxis in cardiovascular surgery Eur J Cardiothorac Surg, October 1, 2000; 18(4): 440 - 446. [Abstract] [Full Text] [PDF]

				S. Harbarth, M. H. Samore, D. Lichtenberg, and Y. Carmeli Prolonged Antibiotic Prophylaxis After Cardiovascular Surgery and Its Effect on Surgical Site Infections and Antimicrobial Resistance Circulation, June 27, 2000; 101(25): 2916 - 2921. [Abstract] [Full Text] [PDF]

				S. M. Gordon, J. M. Serkey RN, T. F. Keys, T. Ryan, C. A. Fatica RN, S. K. Schmitt, J. A. Borsh RN, D. M. Cosgrove III, and J.-P. Yared Secular Trends in Nosocomial Bloodstream Infections in a 55-Bed Cardiothoracic Intensive Care Unit Ann. Thorac. Surg., January 1, 1998; 65(1): 95 - 100. [Abstract] [Full Text] [PDF]

				U. Niederhauser, M. Vogt, P. Vogt, M. Genoni, A. Kunzli, and M. I. Turina CARDIAC SURGERY IN A HIGH-RISK GROUP OF PATIENTS: IS PROLONGED POSTOPERATIVE ANTIBIOTIC PROPHYLAXIS EFFECTIVE?. J. Thorac. Cardiovasc. Surg., August 1, 1997; 114(2): 162 - 168. [Abstract] [Full Text]

				M. S. Slaughter, M. M. Olson, J. T. Lee Jr, and H. B. Ward A fifteen-year wound surveillance study after coronary artery bypass Ann. Thorac. Surg., November 1, 1993; 56(5): 1063 - 1068. [Abstract] [PDF]

				V. Lonsky, J. Mandak, V. Lonska, V. Rozsival, D. Markova, and J. Kubicek Serum oxacillin and cephazolin levels during cardiopulmonary bypass Perfusion, April 1, 1992; 7(2): 115 - 118. [Abstract] [PDF]

				E. P. Dellinger Antibiotic Prophylaxis of Wound Infections in Skin Surgery: Is 4 Days Too Much? Arch Dermatol, September 1, 1991; 127(9): 1394 - 1395. [Abstract] [PDF]

				M. S. Gelfand, B. P. Simmons, P. Schoettle, O. B. Harrington, F. Martin, E. W. Owen, R. B. Craft, and N. Amarshi Cefamandole versus cefonicid prophylaxis in cardiovascular surgery: A prospective study Ann. Thorac. Surg., March 1, 1990; 49(3): 435 - 439. [Abstract] [PDF]

				F. D. Loop, B. W. Lytle, D. M. Cosgrove, S. Mahfood, M. C. McHenry, M. Goormastic, R. W. Stewart, L. A. R. Golding, and P. C. Taylor Sternal wound complications after isolated coronary artery bypass grafting: Early and late mortality, morbidity, and cost of care Ann. Thorac. Surg., February 1, 1990; 49(2): 179 - 187. [Abstract] [PDF]

				D. Sue, T. A. Salazar, K. Turley, and B. J. Guglielmo Effect of surgical blood loss and volume replacement on antibiotic pharmacokinetics Ann. Thorac. Surg., June 1, 1989; 47(6): 857 - 859. [Abstract] [PDF]

				C. M. Conklin, R. J. Gray, D. Neilson, P. Wong, D. K. Tomita, and J. M. Matloff Determinants of Wound Infection Incidence after Isolated Coronary Artery Bypass Surgery in Patients Randomized to Receive Prophylactic Cefuroxime or Cefazolin Ann. Thorac. Surg., August 1, 1988; 46(2): 172 - 177. [Abstract] [PDF]

				E. P. Dellinger, E. S. Caplan, L. D. Weaver, M. J. Wertz, B. M. Droppert, N. Hoyt, R. Brumback, A. Burgess, A. Poka, S. K. Benirschke, et al. Duration of Preventive Antibiotic Administration for Open Extremity Fractures Arch Surg, March 1, 1988; 123(3): 333 - 339. [Abstract] [PDF]

				P. J. A. van der Starre, P. H. Trienekens, J. E. H.-d. Weerd, F. T. C. Willems, G. J. Kootstra, P. J. C. Huige, and R. F. P. Quik Comparative Study between Two Prophylactic Antibiotic Regimens of Cefamandole during Coronary Artery Bypass Surgery Ann. Thorac. Surg., January 1, 1988; 45(1): 24 - 27. [Abstract] [PDF]

				W. van Oeveren, J. Dankert, W. Wildevuur, and C. R. H. Wildevuur Prophylactic Antibiotic Treatment Prevents Infection after Cardiopulmonary Bypass: A Study in Dogs Ann. Thorac. Surg., May 1, 1987; 43(5): 544 - 549. [Abstract] [PDF]

				D. E. Lilienfeld, D. Vlahov, J. H. Tenney, and J. S. McLaughlin On Antibiotic Prophylaxis in Cardiac Surgery: A Risk Factor for Wound Infection Ann. Thorac. Surg., December 1, 1986; 42(6): 670 - 674. [Abstract] [PDF]

				R. M. Nelson and D. J. Dries The Economic Implications of Infection in Cardiac Surgery Ann. Thorac. Surg., September 1, 1986; 42(3): 240 - 246. [Abstract] [PDF]

				R. Freeman and F. Gould Review article : Antibiotic prophylaxis for cardiac surgery Perfusion, January 1, 1986; 1(2): 75 - 79. [PDF]

				E. P. Dellinger, M. J. Wertz, E. S. Lennard, and M. R. Oreskovich Efficacy of Short-Course Antibiotic Prophylaxis After Penetrating Intestinal Injury: A Prospective Randomized Trial Arch Surg, January 1, 1986; 121(1): 23 - 30. [Abstract] [PDF]

				R. PLATT, A. MUNOZ, J. STELLA, S. VanDEVANTER, and J. K. KOSTER Jr. Antibiotic Prophylaxis for Cardiovascular Surgery: Efficacy with Coronary Artery Bypass Ann Intern Med, December 1, 1984; 101(6): 770 - 774. [Abstract] [PDF]

				M. G. Sarr, V. L. Gott, and T. R. Townsend Mediastinal Infection after Cardiac Surgery Ann. Thorac. Surg., October 1, 1984; 38(4): 415 - 423. [Abstract] [PDF]

				[i.]e. Hilton, C. W. Lerner, [i.]a. D. Lowy, and M. L. Tapper [ill]ulture-Negative' Prosthetic [ill]alve Endocarditis: [ill]azards of Postoperative Steroid Therapy [ill]r Unexplained Fever Arch Intern Med, October 1, 1984; 144(10): 2083 - 2084. [Abstract] [PDF]

				B. J. Guglielmo, D. C. Hohn, P. J. Koo, T. K. Hunt, R. L. Sweet, and J. E. Conte Jr Antibiotic Prophylaxis in Surgical Procedures: A Critical Analysis of the Literature Arch Surg, August 1, 1983; 118(8): 943 - 955. [Abstract] [PDF]

				M. J. DINUBILE Surgery in Active Endocarditis Ann Intern Med, May 1, 1982; 96(5): 650 - 659. [Abstract] [PDF]

				A. T. M. Ghoneim, A. P. Tandon, and M. I. Ionescu Comparative Study of Cefamandole versus Ampicillin plus Cloxacillin: Prophylactic Antibiotics in Cardiac Surgery Ann. Thorac. Surg., February 1, 1982; 33(2): 152 - 158. [Abstract] [PDF]

				M. R. Oreskovich, E. P. Dellinger, E. S. Lennard, M. Wertz, C. J. Carrico, and B. H. Minshew Duration of Preventive Antibiotic Administration for Penetrating Abdominal Trauma Arch Surg, February 1, 1982; 117(2): 200 - 205. [Abstract] [PDF]

				H. Faden Prophylactic Antibiotics in Pediatric Cardiovascular Surgery: Current Practices Ann. Thorac. Surg., March 1, 1981; 31(3): 211 - 213. [Abstract] [PDF]

				A. R. L. May, R. C. Darling, D. C. Brewster, and C. S. Darling A Comparison of the Use of Cephalothin and Oxacillin in Vascular Surgery Arch Surg, January 1, 1980; 115(1): 56 - 59. [Abstract] [PDF]